| Hazard Information | Back Directory | [in vivo]
Jolkinolide A (40 mg/kg; i.p.; once every 3 days, for 2 months) inhibits the expression of the VEGF protein in A549 cell xenograft tumor model in mouse[1]. | Animal Model: | Female BALB/c nude mice (4-5 weeks old) injected with A549 cells[1] | | Dosage: | 40 mg/kg | | Administration: | Intraperitoneal injection; once every 3 days for 2 months | | Result: | Significantly inhibited the expression of VEGF protein on the first, 10th, 30th, 45th, and 60th day of administration. |
|
|
| Company Name: |
BioBioPha Co., Ltd.
|
| Tel: |
0871-65217109 13211707573; |
| Website: |
http://www.biobiopha.com |
| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 13348960310 |
| Website: |
https://www.weikeqi-biotech.com/ |
|